The global gene transfer technologies market, valued at US$3.63 billion in 2023, is forecasted to grow at a robust CAGR of ...

Researchers are enhancing the best features of AAV capsids and overcoming their limitations to accelerate gene-based therapies.

Previous research has shown that voretigene neparvovec administered subretinally early in childhood for RPE65-mediated ...

but so unlikely as to be an unnecessary distraction from the pursuit of effective in utero and postnatal gene therapy. Data on gonadal and germ cell vector transfer is relatively easy to gather ...

in “AAV-based Vector Improvements Unrelated to Capsid Protein Modification ... or lipoprotein apheresis. Within the article “Gene Transfer and Genome Editing for Familial Hypercholesterolemia,” ...

Some of these practices are already necessary as a result of new legislation, such as avoiding superfluous DNA transfer (vector sequences) and replacing selectable marker genes commonly used in ...

Parameters for each trading rule are represented with a one-dimensional vector that can be thought of as a chromosome in genetic terms. Meanwhile, the values used in each parameter can be thought ...

Transfer rumors from the Premier League, La Liga, Serie A, Bundesliga and Major League Soccer.

ReiThera is proud to announce a new partnership with SillaJen through a comprehensive Master Service Agreement (MSA), which establishes ReiThera as the manufacturing partner for SillaJen’s innovative ...

which accelerates gene therapy vector engineering by generating high-performance out-of-distribution capsid proteins. About Dyno Therapeutics Dyno Therapeutics is building high-performance genetic ...